The quality on the evidence is good, from scientific tests at reduced chance of bias, of long duration, with clinically valuable outcomes, and with huge figures of contributors. A crucial getting is that some patients will not have a valuable gain with pregabalin, and for those men and women another therapeutic intervention ought to be tried out. T